Comparison of invasive fungal diseases between patients with acute myeloid leukemia receiving posaconazole prophylaxis and those not receiving prophylaxis: A single-center, observational, case-control study in South Korea

Posaconazole prophylaxis is effective in decreasing the incidence of invasive fungal diseases (IFDs) in patients with acute myeloid leukemia (AML). However, the use of antifungal prophylaxis varies in real-life practice, and only a small number of studies have compared the incidence of IFDs between...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Eunmi, Choi, Eun-Ji, Park, Han-Seung, Lee, Sang-Oh, Choi, Sang-Ho, Kim, Yang Soo, Lee, Jung-Hee, Lee, Je-Hwan, Lee, Kyoo-Hyung, Kim, Sung-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137049/
https://www.ncbi.nlm.nih.gov/pubmed/34011022
http://dx.doi.org/10.1097/MD.0000000000025448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137049/
https://www.ncbi.nlm.nih.gov/pubmed/34011022
http://dx.doi.org/10.1097/MD.0000000000025448

Ejemplares similares